scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1097-2765(03)00454-4 |
P8608 | Fatcat ID | release_fnouychfpndw3lth2tld57k4nq |
P3181 | OpenCitations bibliographic resource ID | 2890743 |
P698 | PubMed publication ID | 14690607 |
P5875 | ResearchGate publication ID | 5542037 |
P50 | author | Jun Liu | Q42230328 |
Gilbert G Privé | Q56458223 | ||
P2093 | author name string | Ari Melnick | |
Jonathan D Licht | |||
Shinichiro Takahashi | |||
Denis Bouchard | |||
Sebastian Mayer | |||
Stuart Lax | |||
Chih-Li Kiang | |||
K Farid Ahmad | |||
P2860 | cites work | Crystal structure of the BTB domain from PLZF | Q22003945 |
Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function | Q22009393 | ||
Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex | Q24290565 | ||
Class II histone deacetylases are directly recruited by BCL6 transcriptional repressor | Q24293128 | ||
Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal | Q24306895 | ||
The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis | Q24531167 | ||
The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase | Q24548870 | ||
A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain | Q24554296 | ||
SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor α (RARα) and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia | Q24653689 | ||
Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B | Q24657661 | ||
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination | Q26778405 | ||
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures | Q26778412 | ||
Structure of the enabled/VASP homology 1 domain-peptide complex: a key component in the spatial control of actin assembly | Q27618321 | ||
Crystal structure of the tetramerization domain of the Shaker potassium channel | Q27757284 | ||
Automated MAD and MIR structure solution | Q27861114 | ||
The POZ domain: a conserved protein-protein interaction motif | Q28115868 | ||
The kelch repeat superfamily of proteins: propellers of cell function | Q28140778 | ||
Assembly of Cell Regulatory Systems Through Protein Interaction Domains | Q28155799 | ||
Regulatory mechanisms that determine the development and function of plasma cells | Q28202747 | ||
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program | Q28216493 | ||
The proto-oncogene BCL-6 in normal and malignant B cell development | Q28216775 | ||
Role of the histone deacetylase complex in acute promyelocytic leukaemia | Q28263534 | ||
Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein | Q28273724 | ||
Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6 | Q28284917 | ||
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia | Q29616211 | ||
The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains | Q29618469 | ||
Functions of WW domains in the nucleus | Q32062472 | ||
BCL-6 in the pathogenesis of non-Hodgkin's lymphoma | Q33917162 | ||
Biotinylation of proteins in vivo and in vitro using small peptide tags | Q33921947 | ||
In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions | Q33965235 | ||
EVH1 domains: structure, function and interactions | Q34120295 | ||
Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. | Q34307999 | ||
Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. | Q34324111 | ||
The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development. | Q34372231 | ||
Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas | Q34380954 | ||
Mechanisms of chromosomal translocations in B cell lymphomas | Q34405423 | ||
Translocations of the RARalpha gene in acute promyelocytic leukemia | Q34435522 | ||
Transcriptional regulation in acute promyelocytic leukemia. | Q34435531 | ||
The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. | Q34480893 | ||
Regulation of gene expression by the proto-oncogene BCL-6. | Q34498083 | ||
Gene expression profiling of lymphoid malignancies | Q34511542 | ||
The ZiN/POZ domain of ZF5 is required for both transcriptional activation and repression | Q34627024 | ||
Ambivalent role of BCL6 in cell survival and transformation | Q35055621 | ||
BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells | Q36371299 | ||
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein | Q36594782 | ||
A PDZ domain-based assay for measuring HIV protease activity: assay design considerations | Q38357552 | ||
GAGA can mediate enhancer function in trans by linking two separate DNA molecules | Q39646973 | ||
The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression. | Q39725251 | ||
A new functional domain of Bcl6 family that recruits histone deacetylases | Q42824972 | ||
Mutation of BCL-6 Gene in Normal B Cells by the Process of Somatic Hypermutation of Ig Genes | Q47982616 | ||
Sequence-specific DNA Binding and Transcriptional Regulation by the Promyelocytic Leukemia Zinc Finger Protein | Q52192845 | ||
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma | Q52548831 | ||
Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. | Q54147247 | ||
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. | Q55034216 | ||
BCL-6 regulates chemokine gene transcription in macrophages | Q74268408 | ||
P433 | issue | 6 | |
P304 | page(s) | 1551-64 | |
P577 | publication date | 2003-12-01 | |
P1433 | published in | Molecular Cell | Q3319468 |
P1476 | title | Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain | |
P478 | volume | 12 |
Q39581482 | A BTB domain-containing gene is upregulated by immune challenge. |
Q24307672 | A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells |
Q27660498 | A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo |
Q39116273 | A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters |
Q34144764 | A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. |
Q33228615 | A peptide aptamer to antagonize BCL-6 function. |
Q37157963 | A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo |
Q36315575 | A role for Kaiso-p120ctn complexes in cancer? |
Q40138108 | Aberrant association of promyelocytic leukemia protein-retinoic acid receptor-alpha with coactivators contributes to its ability to regulate gene expression |
Q24336527 | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase |
Q92424125 | Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma |
Q38160822 | An evolving understanding of nuclear receptor coregulator proteins. |
Q35008690 | Arabidopsis thaliana BTB/ POZ-MATH proteins interact with members of the ERF/AP2 transcription factor family |
Q37184358 | B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. |
Q36839342 | B-cell lymphoma 6 promotes proliferation and survival of trophoblastic cells |
Q47269833 | BCL6 as a therapeutic target for lymphoma |
Q36684951 | BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition |
Q33902336 | BCL6 is critical for the development of a diverse primary B cell repertoire |
Q34633877 | BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms |
Q40267907 | BCL6 promotes glioma and serves as a therapeutic target. |
Q37297138 | BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells |
Q34360164 | BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy |
Q37761495 | BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis |
Q99585656 | BCOR Binding to MLL-AF9 Is Essential for Leukemia via Altered EYA1, SIX, and MYC Activity |
Q92478381 | Bach1-induced suppression of angiogenesis is dependent on the BTB domain |
Q47773970 | Backbone resonance assignment of the BCL6-BTB/POZ domain |
Q38201872 | Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis |
Q27640577 | Chromatin Insulator Factors Involved in Long-Range DNA Interactions and Their Role in the Folding of the Drosophila Genome |
Q40000240 | Cloning and functional analysis of 5'-upstream region of the Pokemon gene |
Q28475699 | Computational fragment-based binding site identification by ligand competitive saturation |
Q27640942 | Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator |
Q36498049 | CtBP is an essential corepressor for BCL6 autoregulation |
Q35691225 | Cutting edge: Bcl6-interacting corepressor contributes to germinal center T follicular helper cell formation and B cell helper function |
Q35686130 | Cutting edge: T follicular helper cell differentiation is defective in the absence of Bcl6 BTB repressor domain function |
Q36931136 | Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics |
Q33706071 | Deficiency of the transcriptional repressor B cell lymphoma 6 (Bcl6) is accompanied by dysregulated lipid metabolism |
Q53616483 | Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex |
Q33523241 | EOR-2 is an obligate binding partner of the BTB-zinc finger protein EOR-1 in Caenorhabditis elegans |
Q36740202 | Ectromelia virus BTB/kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases |
Q91587544 | Epigenetic Programing of B-Cell Lymphoma by BCL6 and Its Genetic Deregulation |
Q37987293 | Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance |
Q45812976 | Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank |
Q35739051 | Functional role of dimerization and CP190 interacting domains of CTCF protein in Drosophila melanogaster |
Q53561030 | Genetic analysis of the DBC2 gene in gastric cancer |
Q104073425 | Genetic and epigenetic determinants of diffuse large B-cell lymphoma |
Q39115205 | Genetic factors associated with iron storage in Australian blood donors |
Q89072776 | Genome-wide identification and expression analysis of the BTB domain-containing protein gene family in tomato |
Q37073998 | HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors |
Q89834860 | HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy? |
Q33863009 | Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. |
Q90501746 | Histone deacetylase 3 controls a transcriptional network required for B cell maturation |
Q38440482 | IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells. |
Q58845447 | Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design |
Q42534955 | Inhibiting interactions of lysine demethylase LSD1 with snail/slug blocks cancer cell invasion |
Q36315919 | Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6 |
Q40856825 | Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex |
Q35641806 | Integrity of the Mod(mdg4)-67.2 BTB domain is critical to insulator function in Drosophila melanogaster |
Q37774667 | Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas |
Q36288848 | Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia |
Q36703936 | Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms |
Q33946996 | Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. |
Q24305562 | MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation |
Q38632961 | Mechanisms of action of BCL6 during germinal center B cell development |
Q54506493 | Mediator CDK subunits are platforms for interactions with various chromatin regulatory complexes |
Q47257087 | Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila. |
Q64088977 | Molecular basis of cullin-3 (Cul3) ubiquitin ligase subversion by vaccinia virus protein A55 |
Q35033154 | Molecular modeling and molecular dynamics simulation study of the human Rab9 and RhoBTB3 C-terminus complex |
Q83186138 | NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic |
Q28597074 | Novel Nuclear Factor-KappaB Targeting Peptide Suppresses β-Amyloid Induced Inflammatory and Apoptotic Responses in Neuronal Cells |
Q88630611 | Novel splice isoforms of pig myoneurin and their diverse mRNA expression patterns |
Q37934059 | Nuclear hormone receptor co-repressors: structure and function. |
Q41954532 | Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis |
Q38702294 | Overexpression of B-cell lymphoma 6 alters gene expression profile in a myeloma cell line and is associated with decreased DNA damage response |
Q35906761 | POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function |
Q41824952 | PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells |
Q34012833 | Plant immunity requires conformational changes [corrected] of NPR1 via S-nitrosylation and thioredoxins |
Q36109663 | Predicting the effect of transcription therapy in hematologic malignancies |
Q38022591 | Promising Personalized Therapeutic Options for Diffuse Large B-cell Lymphoma Subtypes with Oncogene Addictions |
Q40975965 | Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphoma |
Q38850477 | Regulation of hematopoietic development by ZBTB transcription factors |
Q36787492 | Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells |
Q24318183 | RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells |
Q58110760 | Rifabutin induced multinucleated hepatocytes in rats: an overview with future prospects |
Q24812693 | Sequence and structural analysis of BTB domain proteins |
Q39320384 | Sequential transcription factor targeting for diffuse large B-cell lymphomas |
Q36284970 | Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression |
Q35672134 | Son maintains accurate splicing for a subset of human pre-mRNAs |
Q52085890 | Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells |
Q36407702 | Structural Characterization of the SMRT Corepressor Interacting with Histone Deacetylase 7. |
Q34762436 | Structural assembly of cullin-RING ubiquitin ligase complexes |
Q27666601 | Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery |
Q33771012 | Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors. |
Q51420255 | Structural insights into the interaction of human p97 N-terminal domain and SHP motif in Derlin-1 rhomboid pseudoprotease |
Q27649873 | Structure of a BCOR Corepressor Peptide in Complex with the BCL6 BTB Domain Dimer |
Q27655343 | Structure of the human Nac1 POZ domain |
Q27653027 | Structure of the wild-type human BCL6 POZ domain |
Q42551653 | Structures of heterodimeric POZ domains of Miz1/BCL6 and Miz1/NAC1. |
Q43164202 | Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6. |
Q35687836 | Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies? |
Q38002489 | The 1‐1‐1 fallacy |
Q39018438 | The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target |
Q37438780 | The KCTD family of proteins: structure, function, disease relevance |
Q27681982 | The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain |
Q34598347 | The pupal specifier broad directs progressive morphogenesis in a direct-developing insect |
Q27676372 | The structure of the Bach2 POZ-domain dimer reveals an intersubunit disulfide bond |
Q34245186 | The transcriptional modulator BCL6 as a molecular target for breast cancer therapy |
Q24298449 | The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties |
Q37188181 | The ubiquitin conjugating enzyme, UbcM2, engages in novel interactions with components of cullin-3 based E3 ligases |
Q81483894 | The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection |
Q40974570 | Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas |
Q37152753 | Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas |
Q35064355 | Transcriptional and epigenetic networks of helper T and innate lymphoid cells. |
Q55425762 | Zbtb7a is a transducer for the control of promoter accessibility by NF-kappa B and multiple other transcription factors. |
Q40097554 | Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs |
Search more.